Testing the Effects of an Algorithm for Neuropathic Pain on Patient and System Outcomes

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier:
NCT00130130
First received: August 12, 2005
Last updated: January 30, 2012
Last verified: January 2012
  Purpose

The overall purpose of this project is to improve nurse skills regarding neuropathic pain (NP) assessment, treatment and referral practices through implementation of an evidence-based algorithm and to improve selected patient outcomes as a result of algorithm use.


Condition Phase
Pain
Phase 1
Phase 2

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Testing the Effects of an Algorithm for Neuropathic Pain on Patient and System Outcomes

Further study details as provided by Dartmouth-Hitchcock Medical Center:

Primary Outcome Measures:
  • To implement an evidence based screening, assessment, treatment, and referral guideline for hematology/oncology patients with NP receiving care [ Time Frame: outcome measures will consist of the NPVAS, and a PPCPS adapted rom the original project. Adequate satisfaction will be defined as 25% or mor of all patients reporting being very or completely satisfied as measured by PPCPS ] [ Designated as safety issue: No ]

Enrollment: 20
Study Start Date: August 2005
Study Completion Date: December 2011
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Detailed Description:

Neuropathic pain (NP) is defined as pain that arises from injury, disease or dysfunction of the central or peripheral nervous system. For the patient focused phase of the project NP treatment will be guided via the Peripheral Neuropathy Treatment Algorithm. Patients will receive algorithm-specific treatment for 12 weeks.

  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Cancer patients experiencing NP from a variety of causes

Criteria

Inclusion Criteria:

  • Cancer patients experiencing NP from a variety of causes
  • NP Visual Analogue Scale (VAS) score equal to or > 4 with 12 week estimated duration
  • Karnofsky Performance Status (KPS) 60% or greater
  • Age greater than 18

Exclusion Criteria:

  • Patients undergoing anticancer or invasive pain procedures specifically intended to palliate NP are ineligible
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00130130

Locations
United States, New Hampshire
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756
Sponsors and Collaborators
Dartmouth-Hitchcock Medical Center
Investigators
Principal Investigator: Ellen Lavoie-Smith, ARNP Dartmouth-Hitchcock Medical Center
  More Information

No publications provided

Responsible Party: Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier: NCT00130130     History of Changes
Other Study ID Numbers: D 0403, ONS
Study First Received: August 12, 2005
Last Updated: January 30, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Neuralgia
Pain
Neurologic Manifestations
Nervous System Diseases
Peripheral Nervous System Diseases
Neuromuscular Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on August 27, 2014